HeartBeam Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Rob Eno
Chief executive officer
US$2.6m
Total compensation
| CEO salary percentage | 13.5% |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | 1.4yrs |
Recent management updates
Recent updates
Here's Why We're Watching HeartBeam's (NASDAQ:BEAT) Cash Burn Situation
Sep 19
Companies Like HeartBeam (NASDAQ:BEAT) Could Be Quite Risky
Jan 17HeartBeam gets a new chief medical officer
Oct 11HeartBeam gets patent to enable generation of its credit card-sized ECG, shares rise ~15%
Sep 28HeartBeam surges 54% on U.S. patent for ECG patch monitor to detect heart attacks
Sep 15HeartBeam GAAP EPS of $0.43 beats by $0.70
Aug 11HeartBeam: Cardiovascular Diagnostics On The Go
Dec 14CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$18m |
| Jun 30 2024 | n/a | n/a | -US$17m |
| Mar 31 2024 | n/a | n/a | -US$15m |
| Dec 31 2023 | US$3m | US$345k | -US$15m |
Compensation vs Market: Rob's total compensation ($USD2.55M) is above average for companies of similar size in the US market ($USD652.28K).
Compensation vs Earnings: Insufficient data to compare Rob's compensation with company performance.
CEO
Rob Eno
less than a year
Tenure
US$2,552,204
Compensation
Mr. Robert P. Eno, also known as Rob, is Chief Executive Officer of HeartBeam, Inc. since October 21, 2024 and serves as its Chief Business Officer and was President from January 18, 2023 to October 21, 20...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 5.8yrs | US$238.59k | 0.64% $ 486.2k | |
| CEO & Chief Business Officer | less than a year | US$2.55m | no data | |
| Founder | less than a year | US$3.25m | 3.43% $ 2.6m | |
| Chief Technology Officer | 2.3yrs | US$1.41m | 0% $ 0 | |
| Chief Financial Officer | less than a year | no data | no data | |
| Member of Scientific Advisory Board & Chief Medical Officer | 2.1yrs | no data | no data | |
| Senior Vice President of Product | 1.2yrs | no data | no data |
0.7yrs
Average Tenure
68yo
Average Age
Experienced Management: BEAT's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 5.8yrs | US$238.59k | 0.64% $ 486.2k | |
| Founder | no data | US$3.25m | 3.43% $ 2.6m | |
| Member of Scientific Advisory Board & Chief Medical Officer | less than a year | no data | no data | |
| Independent Director | 1.4yrs | US$104.72k | 1.03% $ 778.3k | |
| Independent Director | no data | US$152.50k | 0.090% $ 68.1k | |
| Independent Director | 1.3yrs | US$148.65k | 0.053% $ 39.7k | |
| Independent Director | no data | US$140.64k | 1.47% $ 1.1m | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | no data | US$140.00k | 0.36% $ 272.5k | |
| Chairman of Scientific Advisory Board | 2.8yrs | no data | no data | |
| Independent Director | 1.4yrs | US$102.60k | 0.35% $ 266.9k | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
1.4yrs
Average Tenure
66.5yo
Average Age
Experienced Board: BEAT's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.